2025³â 08¿ù 09ÀÏ Åä¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > Àαⴺ½º

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
 
¸ðµÎ 92622°³ÀÇ ´º½º°¡ °Ë»öµÇ¾ú½À´Ï´Ù.



¡®±ñdzġŲ »À ¹ß¶ó¹ö¸± ¹ß°ñ Àü¹®°¡¡¯ ¸ðÁý¡¦ÀÏ±Þ 100¸¸¿ø

ÀâÄÚ¸®¾Æx¾Ë¹Ù¸óxǪ¶ó´ß º¹³¯ ÀÌ»ö¾Ë¹Ù
ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸ó(´ëÇ¥ÀÌ»ç À±ÇöÁØ)ÀÌ º¹³¯À» ¸Â¾Æ ġŲ Àü¹® ºê·£µå Ǫ¶ó´ß ġŲ°ú ÇÔ²² ÀÌ»ö ¾Ë¹Ù¸¦ ¸ðÁýÇÏ´Â À̺¥Æ®¸¦ ÁøÇàÇÑ´Ù°í 21ÀÏ ¹àÇû´Ù. ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸óÀº ³»´Þ 3ÀϱîÁö Ǫ¶ó´ß ġŲ°ú Çù¾÷ÇØ º¹³¯ ±â³ä ÀÌ»ö °ø°í¸¦ ³»°í ‘±ñdzġŲ »À ¹Ù¸¦ ¾Ë¹Ù¸ó’°ú ‘±ñdzġŲ »À ¹ß¶ó¹ö¸± ¹ß°ñ Àü¹®°¡’¸¦ ¸ðÁýÇÑ´Ù. À̹ø À̺¥Æ®´Â ¾Ë¹Ù¸óÀÌ ÁøÇà ÁßÀÎ ´ë±Ô¸ð ÇÁ·Î¸ð¼Ç ‘2025 ¿©¸§ ¾Ë¹Ù Æä½ºÅ¸(¿©¾ËÆä)’ÀÇ ÀÏȯÀÌ´Ù. ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸óÀº ¿©¸§Ã¶ ¹«´õÀ§¿Í ²ß²ßÇÑ ³¯¾¾·Î ÁöÃÄ ÀÖ´Â ±¸Á÷ÀÚµéÀ» À§ ...

Novotech Report: How In-Vivo CAR-T May Reshape Cell Therapy Econo...
SYDNEY -- With in-vivo CAR-T therapies gaining global momentum, a new whitepaper from Novotech, a leading global full-service clinical Contract Research Organization (CRO) and scientific advisory company, offers insight into this next frontier of immunotherapy. In-Vivo CAR Therapies - Global Research and Development Landscape (2025) report explores the accelerating innovation in in-vivo CAR-T (Chimeric Antigen Receptor) technologies and their potential to reshape treatment across oncology, autoi ...

¡®ÇÏÆ®Æä¾î¸µ¡¯ Æä¾î¸µºÏ, 33°¡Áö Áú¹®ÀÇ ´äÀÌ Ã¥ÀÌ µÆ´Ù

½Ì±ÛÀÎ ÀÌû¾Æ, Ãֽÿø, ¹Ì¹Ì ´äº¯ÀÌ ±Ã±ÝÇÒ Á¤µµ·Î °¡Ä¡ Àִ å
ä³ÎA »õ ¿¬¾Ö ¿¹´É ‘ÇÏÆ®Æä¾î¸µ’ÀÌ Ã¹ ÃÔ¿µºÎÅÍ ‘°ú¸ôÀÔ’¿¡ ºüÁø 5MC À±Á¾½Å-ÀÌû¾Æ-Ãֽÿø-¹Ì¹Ì-¹ÚÁö¼± ±³¼öÀÇ ½ºÆ©µð¿À ÃÔ¿µ ½ºÆ¿À» °ø°³Çß´Ù. 3¿ù 7ÀÏ(±Ý) ¹ã 10½Ã 50ºÐ ù ¹æ¼ÛÇϴ ä³ÎA ‘ÇÏÆ®Æä¾î¸µ’Àº °áÈ¥ÇÏ°í ½ÍÀº ûÃáµéÀÇ ³¶¸¸°ú ÇöŸ Ãæ¸¸ÇÑ È¥Àü ¿¬¾Ö Àϱ⸦ ±×·Á³»´Â ¿¬¾Ö ÇÁ·Î±×·¥ÀÌ´Ù. ÀÌÁ¦´Â °áÈ¥ÇÒ »ç¶÷°ú ¿¬¾ÖÇÏ°í ½ÍÀº ûÃá³²³àµéÀÌ ´Ü¼øÇÑ ‘½æ’À» ³Ñ¾î, °áÈ¥ »ó´ë¸¦ ã±â À§ÇØ ÁøÁöÇÏ°Ô ¼­·Î¸¦ ¾Ë¾Æ°¡´Â °úÁ¤À» ´ã¾Æ³½´Ù. Ã⿬ÁøµéÀº Áö³­ÇØ ¸» ¾Æ¸§´Ù¿î ³¶¸¸ ...
New NetApp Storage Offerings Modernize Workloads for Busines... (2024-11-20)
¸Ó½½¸¶´Ï¾Æ Á¤ÀÎÇý¡¤ÀÌ¿¬¡¦ ȯ»ó ¸ö¸Å ºñ°áÀº ´Ü¹éÁú Çコº¸ÃæÁ¦ (2015-06-06)
AGCO Continues Technology Transformation to Become an Indust... (2023-11-13)
¡®°­Ã¶ºÎ´ë3¡¯ »ì¹úÇÑ ¡®Å¸ÀÌ¾î °ÝÅõ¡¯ ÇöÀå (2023-10-17)
19´ë ±¹È¸ ±¹°¨ ±â¾÷ÀÎ ÁõÀÎ ¼ö, 16´ë ±¹È¸º¸´Ù µÎ ¹è (2015-09-22)
Medisca Expands Strategic Partnerships to Drive Patient Acce... (2023-07-28)
»ï¼ºÀüÀÚ, Å©·¡ÇÁÅæ°ú ¡®´ÙÅ©¾Ø´ÙÄ¿ ¸ð¹ÙÀÏ¡¯ °ÔÀÓ Çù¾÷ (2024-08-04)
Åõ½æÇ÷¹À̽º, ¡®ºñºñ¡¯ÀÇ ¸ðµ¨ ¹ßŹ ±â³ä À½·á ¼±ºÄ (2024-05-11)
±ºÀΰøÁ¦È¸¿ø »ýȰ¾ÈÁ¤ ¹× º¹ÁöÁõÁø ¡®ÅðÁ÷±Þ¿©´ë¿©¡¯ (2023-12-24)
¼¼°è ¾ØÆ²·¯ ÆÝµå ¸Å´ÏÀúµé ¼­¿ï·Î Áý°á (2024-06-11)
¹Ð°É·¹ÀÇ Å»¼ö¿Í °ÉÀÌ ±â´É, ÇϳªÀÇ ¾çµ¿ÀÌ·Î (2015-11-03)
GS25, Çѱ¹µµ·Î°ø»ç¿Í ¡®ÈÞ°Ô¼Ò Àαâ À½½Ä¡¯ »óǰȭ MOU (2024-07-10)
First Doses of BRUKINSA provided to Patients with Chronic Ly... (2024-03-20)
¡®¸®¾ó ¿¬¾Ö½ÇÇè½Ç µ¶»ç°ú¡¯ ½Ãû·üXÈ­Á¦¼º ´Ù Àâ¾Ò´Ù (2024-06-13)
»ï¼º¹°»ê ·¡¹Ì¾È, VR ±â¼ú·Î ÀÔÁÖ °í°´ AS Æí¸®ÇØÁø´Ù (2024-05-17)
Pharmanovia Signs Novel Biologic In-Licensing Agreement With... (2024-11-30)
Çö´ëÂ÷ Á¤¸ù±¸ Àç´Ü, ÀÓÆÑÆ® ½ºÅ¸Æ®¾÷ Ä·ÇÁ °³ÃÖ (2024-05-19)
¹Ý·Áµ¿¹°ÀÇ °üÀý¡¤½½°³°ñ ¿µ¾çÁ¦ ¡®ÆêÁöŰ¹Ì º»ÅõÆê¡¯ Ãâ½Ã (2024-06-17)
KB±¹¹ÎÀºÇà, ¡®¼­¹Î±ÝÀ¶ÁøÈï¿ø Ã⿬ Çù¾à¡¯ ü°á (2024-05-21)
»ï¼ºÀüÀÚ ¡®´õ ÇÁ·¹ÀÓ¡¯À¸·Î »ì¹Ùµµ¸£ ´Þ¸® ÀÛǰ ¸¸³­´Ù (2023-08-17)
Puma Reimagines Modern Retail With Las Vegas Flagship Store ... (2024-12-04)
BNKºÎ»êÀºÇà ¡®²ÞÀÌ·ë Àû±Ý¡¯ ¸®´º¾ó Ãâ½Ã (2024-06-23)
Á¦ÁÖâÁ¶°æÁ¦Çõ½Å¼¾ÅÍ ÅõÀÚ±â¾÷ ù »óÀ塦 ÁÖÀΰø ¡®ÄÁÅØ¡¯ (2023-11-16)
¼Õ´Ô Áß½ÉÀÇ »ýȰ±ÝÀ¶»ýŰè È®Àå ³ª¼±´Ù (2023-11-18)
NIKE, Inc. Appoints Long-Time Leaders Ann Miller as EVP, Glo... (2024-11-09)
       [ÀÌÀü][1]....[595][596][597][598][599][600][601][602][603]...[3705][´ÙÀ½]

°øÁö»çÇ×
´º½ºÁö ÇÑÀÚ Ç¥±â¿¡ ´ë¸¸½Ä À½Â÷ Ç¥±â '纽ÞÙó¢ ´Ï¿ì½ÃÁö' º´±â
º£³×ÇÁ·Ò º£³×ÀÎÅõ Áß¹® Ç¥±â 宝Ò¬ÜØÙÌ 宝Ò¬ì×öõ(ÜÄÒ¬ÜØÙÌ ÜÄ...
¹Ìµð¾î¾Æ¿ì¾î Mediaour ØÚ体ä²们 ØÚô÷ä²Ùú MO ¿¥¿À ØÚä² ØÚä²
¾Ë¸®¿ìºê Alliuv ä¹备: ä¹联êó备, ¾Ë¶ã Althle ä¹÷åìÌ
¾Ë¸®¾Ë Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º : À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¹ÙÀÌ¿ÀÀÌ´Ï Bioini Áß¹® Ç¥±â ù±药研 ù±å·æÚ
¿À½ºÇÁ·Ò Ausfrom 奥ÞÙÜØÙÌ, À£ÇÁ·Ò Welfrom 卫ÜØÙÌ
¿¡³ÊÇÁ·Ò Enerfrom 额ÒöÜØÙÌ ¿¡³ÊÀ¯ºñ Eneruv 额Òöêó备
¾ËÇÁ·Ò Alfrom Áß¹® Ç¥±â ä¹尔ÜØÙÌ ä¹ì³ÜØÙÌ
 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..